<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00388934</url>
  </required_header>
  <id_info>
    <org_study_id>SORT-OUT II</org_study_id>
    <nct_id>NCT00388934</nct_id>
  </id_info>
  <brief_title>Comparison of Cypher Select and Taxus Express Coronary Stents</brief_title>
  <acronym>SORT-OUTII</acronym>
  <official_title>Randomized Clinical Comparison of Cypher Select and Taxus Express Stent Implantation in Unselected Patients With Coronary Artery Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aarhus University Hospital Skejby</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Aarhus</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Aarhus University Hospital Skejby</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Randomized nine months clinical comparison of implantation of Taxol eluting (Taxus Express)&#xD;
      and Sirolimus eluting (Cypher Select) stents in non-selected patients with coronary artery&#xD;
      disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Design:&#xD;
&#xD;
        -  Randomized open multicentre trial.&#xD;
&#xD;
      Patients:&#xD;
&#xD;
        -  1800 patients with coronary artery disease scheduled for percutaneous coronary&#xD;
           intervention with stent implantation.&#xD;
&#xD;
      Inclusion criteria:&#xD;
&#xD;
        -  Patients with coronary artery disease scheduled for percutaneous coronary intervention&#xD;
           with stent implantation.&#xD;
&#xD;
        -  Signed informed consent.&#xD;
&#xD;
      Exclusion criteria:&#xD;
&#xD;
        -  Participation in other stent studies.&#xD;
&#xD;
      Randomization:&#xD;
&#xD;
        -  Implantation of Taxus Express og Cypher Select stents.&#xD;
&#xD;
      Primary end-point:&#xD;
&#xD;
        -  Combined end-point of cardiac death, new revascularization (PCI or CABG) or myocardial&#xD;
           infarction after nine months.&#xD;
&#xD;
      Secondary end-points:&#xD;
&#xD;
        -  Total death after nine months&#xD;
&#xD;
        -  Cardiac death after nine months&#xD;
&#xD;
        -  Myocardial infarction after nine months&#xD;
&#xD;
        -  Index vessel myocardial infarction after nine months&#xD;
&#xD;
        -  Target lesion revascularization&#xD;
&#xD;
        -  Target vessel revascularization&#xD;
&#xD;
        -  Stent thrombosis after nine months&#xD;
&#xD;
      End-point evaluation:&#xD;
&#xD;
        -  End-points will be adjudicated by an independent end-point committee&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2004</start_date>
  <completion_date type="Actual">January 2009</completion_date>
  <primary_completion_date type="Actual">January 2006</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>MACE (cardiac death, myocardial infarction, target vessel revascularisation, target lesion revascularisation, TVF)</measure>
    <time_frame>during 9 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Total death</measure>
    <time_frame>after 9 months, 2 and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>after 9 months, 2 and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>after 9 months, 2 and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularisation, target lesion revascularisation, TVF</measure>
    <time_frame>after 9 months, 2 and 3 years</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>after 9 months, 2 and 3 years</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">2095</enrollment>
  <condition>Coronary Artery Disease</condition>
  <condition>Angina Pectoris</condition>
  <arm_group>
    <arm_group_label>Drug eluting stent (Cypher)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous coronary intervention with implantation of drug eluting coronary stent (Cypher)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Drug eluting stent (Taxus)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Percutaneous coronary intervention with implantation of drug eluting coronary stent (Taxus)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Drug eluting stent</intervention_name>
    <description>percutaneous intervention with implantation of drug eluting coronary stent</description>
    <arm_group_label>Drug eluting stent (Cypher)</arm_group_label>
    <arm_group_label>Drug eluting stent (Taxus)</arm_group_label>
    <other_name>DES</other_name>
    <other_name>Cypher</other_name>
    <other_name>Taxus</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Planned implantation of drug eluting stent&#xD;
&#xD;
          -  Written informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Planned intervention with other stents than study stents&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Anders Galloe, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Gentofte Hospital, Copenhagen</affiliation>
  </overall_official>
  <verification_date>May 2007</verification_date>
  <study_first_submitted>October 16, 2006</study_first_submitted>
  <study_first_submitted_qc>October 16, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 17, 2006</study_first_posted>
  <last_update_submitted>July 29, 2013</last_update_submitted>
  <last_update_submitted_qc>July 29, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 30, 2013</last_update_posted>
  <responsible_party>
    <name_title>Department of Cardiology B</name_title>
    <organization>Aarhus University Hospital Skejby</organization>
  </responsible_party>
  <keyword>Percutaneous coronary intervention</keyword>
  <keyword>Angina pectoris</keyword>
  <keyword>Stent</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Disease</mesh_term>
    <mesh_term>Angina Pectoris</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

